{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T18:09:31Z","timestamp":1775239771053,"version":"3.50.1"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["canadianjournalofdiabetes.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Diabetes"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.jcjd.2015.09.009","type":"journal-article","created":{"date-parts":[[2015,11,30]],"date-time":"2015-11-30T07:45:15Z","timestamp":1448869515000},"page":"S155-S159","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"S5","title":["The Role of Hypoglycemia in Cardiovascular Outcomes in Diabetes"],"prefix":"10.1016","volume":"39","author":[{"given":"Breay W.","family":"Paty","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcjd.2015.09.009_bib0010","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJM199807233390404","article-title":"Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction","volume":"339","author":"Haffner","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcjd.2015.09.009_bib0015","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications of insulin-dependent diabetes mellitus","volume":"329","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcjd.2015.09.009_bib0020","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","article-title":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)","volume":"352","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.jcjd.2015.09.009_bib0025","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1056\/NEJMoa0802987","article-title":"Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes","volume":"358","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcjd.2015.09.009_bib0030","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1056\/NEJMoa021778","article-title":"Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes","volume":"348","author":"Gaede","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcjd.2015.09.009_bib0035","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","article-title":"10-year follow-up of intensive glucose control in type 2 diabetes","volume":"359","author":"Holman","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcjd.2015.09.009_bib0040","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1056\/NEJMoa1414266","article-title":"VADT Investigators. Follow-up of glycemic control and cardiovascular outcomes in type 2 diabetes","volume":"372","author":"Hayward","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcjd.2015.09.009_bib0045","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1056\/NEJMoa1006524","article-title":"Long-term effects of intensive glucose lowering on cardiovascular outcomes","volume":"364","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcjd.2015.09.009_bib0050","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1056\/NEJMoa0808431","article-title":"Glucose control and vascular complications in veterans with type 2 diabetes","volume":"360","author":"Investigators","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcjd.2015.09.009_bib0055","first-page":"b5444","article-title":"The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: Retrospective epidemiological analysis of the ACCORD study","volume":"339","author":"Bonds","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.jcjd.2015.09.009_bib0060","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1007\/s00125-002-0822-9","article-title":"Hypoglycaemia: The limiting factor in the glycaemic management of type I and type II diabetes","volume":"45","author":"Cryer","year":"2002","journal-title":"Diabetologia"},{"key":"10.1016\/j.jcjd.2015.09.009_bib0065","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1001\/jama.1984.03350240024032","article-title":"Treatment of insulin reactions in diabetics","volume":"252","author":"Brodows","year":"1984","journal-title":"JAMA"},{"key":"10.1016\/j.jcjd.2015.09.009_bib0070","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1016\/j.jcjd.2013.01.022","article-title":"Hypoglycemia. Canadian diabetes association clinical practice guidelines","volume":"37","author":"Clayton","year":"2013","journal-title":"Can J Diabetes"},{"key":"10.1016\/j.jcjd.2015.09.009_bib0075","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.2337\/diab.43.11.1378","article-title":"Banting lecture, hypoglycemia: The limiting factor in the management of IDDM","volume":"43","author":"Cryer","year":"1994","journal-title":"Diabetes"},{"key":"10.1016\/j.jcjd.2015.09.009_bib0080","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/0002-9343(91)80085-Z","article-title":"Epidemiology of severe hypoglycemia in the diabetes control and complications trial","volume":"90","year":"1991","journal-title":"Am J Med"},{"key":"10.1016\/j.jcjd.2015.09.009_bib0085","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1210\/jc.2009-2828","article-title":"Determinants of severe hypoglycemia complicating type 2 diabetes: The Fremantle diabetes study","volume":"95","author":"Davis","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jcjd.2015.09.009_bib0090","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ecl.2012.11.005","article-title":"Defective counterregulation and hypoglycemia unawareness in diabetes: Mechanisms and emerging treatments","volume":"42","author":"Reno","year":"2013","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.jcjd.2015.09.009_bib0095","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1056\/NEJMra1215228","article-title":"Mechanisms of hypoglycemia-associated autonomic failure in diabetes","volume":"369","author":"Cryer","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcjd.2015.09.009_bib0100","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.2337\/dc10-0503","article-title":"Proinflammatory and prothrombotic effects of hypoglycemia","volume":"33","author":"Dandona","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcjd.2015.09.009_bib0105","doi-asserted-by":"crossref","first-page":"323","DOI":"10.2174\/1566524053766059","article-title":"Type 2 diabetes: An atherothrombotic syndrome","author":"Dunn","year":"2005","journal-title":"Curr Mol Med"},{"key":"10.1016\/j.jcjd.2015.09.009_bib0110","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.2337\/dc09-0354","article-title":"Effects of acute hypoglycemia on inflammatory and pro-atherothrombotic biomarkers in individuals with type 1 diabetes and healthy individuals","volume":"33","author":"Joy","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcjd.2015.09.009_bib0115","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/dmrr.865","article-title":"Vascular disease and diabetes: Is hypoglycaemia an aggravating factor?","volume":"24","author":"Wright","year":"2008","journal-title":"Diabetes Metab Res Rev"},{"issue":"Suppl. 2","key":"10.1016\/j.jcjd.2015.09.009_bib0120","doi-asserted-by":"crossref","first-page":"S132","DOI":"10.2337\/dc11-s220","article-title":"Hypoglycemia and cardiovascular risks","volume":"34","author":"Frier","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcjd.2015.09.009_bib0125","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.2337\/diabetes.52.6.1469","article-title":"Mechanisms of abnormal cardiac repolarization during insulin-induced hypoglycemia","volume":"52","author":"Robinson","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.jcjd.2015.09.009_bib0130","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1007\/s00125-007-0902-y","article-title":"Effects of controlled hypoglycaemia on cardiac repolarisation in patients with type 1 diabetes","volume":"51","author":"Koivikko","year":"2008","journal-title":"Diabetologia"},{"key":"10.1016\/j.jcjd.2015.09.009_bib0135","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0196-0644(05)82191-2","article-title":"Transient atrial fibrillation precipitated by hypoglycemia","volume":"19","author":"Odeh","year":"1990","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.jcjd.2015.09.009_bib0140","doi-asserted-by":"crossref","first-page":"516","DOI":"10.2337\/dc13-0600","article-title":"Relationship between hypoglycemic episodes and ventricular arrhythmias in patients with type 2 diabetes and cardiovascular diseases: Silent hypoglycemias and silent arrhythmias","volume":"37","author":"Stahn","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcjd.2015.09.009_bib0145","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.amjmed.2011.08.008","article-title":"Death during intensive glycemic therapy of diabetes: Mechanisms and implications","volume":"124","author":"Cryer","year":"2011","journal-title":"Am J Med"},{"key":"10.1016\/j.jcjd.2015.09.009_bib0150","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1007\/s00125-007-0824-8","article-title":"Early mortality in EURODIAB population-based cohorts of type 1 diabetes diagnosed in childhood since 1989","volume":"50","author":"Patterson","year":"2007","journal-title":"Diabetologia"},{"key":"10.1016\/j.jcjd.2015.09.009_bib0155","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s00125-005-0082-6","article-title":"Long-term mortality in a nationwide cohort of childhood onset type 1 diabetic patients in Norway","volume":"49","author":"Skrivarhaug","year":"2006","journal-title":"Diabetologia"},{"key":"10.1016\/j.jcjd.2015.09.009_bib0160","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.2337\/dc10-1915","article-title":"Evidence linking hypoglycemic events to an increased risk of acute cardiovascular events in patients with type 2 diabetes","volume":"34","author":"Johnston","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcjd.2015.09.009_bib0165","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1056\/NEJMoa011300","article-title":"Intensive insulin therapy in critically ill patients","volume":"345","author":"Van den Berghe","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcjd.2015.09.009_bib0170","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1056\/NEJMoa052521","article-title":"Intensive insulin therapy in the medical ICU","volume":"354","author":"Van den Berghe","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcjd.2015.09.009_bib0175","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1056\/NEJMoa0810625","article-title":"Intensive versus conventional glucose control in critically ill patients","volume":"360","author":"NICE-SUGAR Study Investigators","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcjd.2015.09.009_bib0180","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1056\/NEJMoa1204942","article-title":"Hypoglycemia and risk of death in critically ill patients","volume":"367","author":"NICE-SUGAR Study Investigators","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcjd.2015.09.009_bib0185","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1056\/NEJMe1208208","article-title":"Understanding low sugar from NICE-SUGAR","volume":"367","author":"Hirsch","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcjd.2015.09.009_bib0190","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/S0002-9149(99)80683-3","article-title":"Effect of intensive diabetes management on macrovascular events and risk factors in the Diabetes Control and Complications Trial","volume":"75","year":"1995","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jcjd.2015.09.009_bib0195","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1056\/NEJMoa052187","article-title":"Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes","volume":"353","author":"Nathan","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcjd.2015.09.009_bib0200","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2337\/dc13-2116","article-title":"Update on cardiovascular outcomes at 30 years of the Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications study","volume":"37","author":"Lachin","year":"2014","journal-title":"Diabetes Care"},{"issue":"Suppl. 1","key":"10.1016\/j.jcjd.2015.09.009_bib0210","first-page":"S27","article-title":"Implications of the United Kingdom Prospective Diabetes Study","volume":"23","author":"American Diabetes Association","year":"2000","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcjd.2015.09.009_bib0215","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2337\/dc08-9026","volume":"32","author":"Skyler","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcjd.2015.09.009_bib0220","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1056\/NEJMoa1003795","article-title":"Severe hypoglycemia and risks of vascular events and death","volume":"363","author":"Zoungas","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcjd.2015.09.009_bib0225","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.b5444","article-title":"The effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: Post hoc epidemiological analysis of the ACCORD study","volume":"340","author":"Miller","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.jcjd.2015.09.009_bib0230","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.2337\/dc10-0125","article-title":"Effects of cardiac autonomic dysfunction on mortality risk in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial","volume":"33","author":"Pop-Busui","year":"2010","journal-title":"Diabetes Care"},{"issue":"Suppl. 1","key":"10.1016\/j.jcjd.2015.09.009_bib0235","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.2337\/dc15-S009","article-title":"Glycemic targets, Sec. 6. In Standards of Medical Care in Diabetes 2015","volume":"38","author":"American Diabetes Association","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcjd.2015.09.009_bib0240","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1093\/eurheartj\/eht108","volume":"34","author":"Ryd\u00e9n","year":"2013","journal-title":"Eur Heart J"}],"container-title":["Canadian Journal of Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1499267115006401?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1499267115006401?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T15:29:15Z","timestamp":1761492555000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1499267115006401"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":46,"alternative-id":["S1499267115006401"],"URL":"https:\/\/doi.org\/10.1016\/j.jcjd.2015.09.009","relation":{},"ISSN":["1499-2671"],"issn-type":[{"value":"1499-2671","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Role of Hypoglycemia in Cardiovascular Outcomes in Diabetes","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Diabetes","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcjd.2015.09.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}